The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Tullow Plunges On Output Guidance Reset

Mon, 09th Dec 2019 10:50

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.

----------

FTSE 100 - WINNERS

----------

Tesco, up 4.9%. The UK's largest supermarket chain confirmed the potential sale of its Asian business, though noted a review of options remains in the early stages. Tesco, which has operations in both Thailand and Malaysia, said the review of the business began after receiving "inbound interest" from potential buyers. The statement from the grocer came after the Times earlier on Monday had reported the company is mulling a potential sale worth up to USD9 billion. "If Tesco were to sell the business, it would need to be at a lumpy premium, and while any proceeds would be a nice cash windfall, one would have to question the long-term strategy of management in adopting such a move, in what could well be a strong business in the years ahead, given how increasingly competitive the UK market is likely to get," commented CMC Markets analyst Michael Hewson.

----------

FTSE 100 - LOSERS

----------

Croda International, down 1.0%. Barclays downgraded the speciality chemicals company to Equal Weight from Overweight.

----------

FTSE 250 - WINNERS

----------

Senior, up 5.6%. The engineer confirmed speculation regarding a review of its Aerostructures business, but said there can be no certainty over any transaction for the business following the review. The Rickmansworth, Hertfordshire-based company added that the Aerostructures review is in line with Senior's policy to review its portfolio and evaluate all its operating businesses in terms of their strategic fit within the group. The Aerostructures business, part of Senior's aerospace unit, manufactures structural parts for original equipment manufacturers in the large, business and regional jet markets. In 2018, the aerospace unit contributed GBP760.4 million to group revenue which totaled GBP1.08 billion.

----------

Marks & Spencer, up 3.5%. Goldman Sachs double upgraded the food, clothing and homewares retailer to Buy from Sell.

----------

FTSE 250 - LOSERS

----------

Tullow Oil, down 57%. The oil and gas company suspended its dividend, "reset" its future production guidance, and said Chief Executive Officer Paul McDade resigned with immediate effect. Following underperformance from its main oil producing assets - the TEN and Jubilee fields in Ghana - Tullow said it needs to reset its forward-looking guidance. For 2020, group production is forecast to average between 70,000 and 80,000 barrels of oil per day and group production for the following three years is expected to average around 70,000 bopd. Further, in 2020, Tullow expects to generate underlying free cash flow of at least USD150 million at USD60 a barrel after a capital investment of USD350 million. Considering the level of expected free cash flow, Tullow decided to suspend its dividend. "The appetite for risk which served it well when exploring for oil and gas arguably left it in a perilous position when it had too much debt heading into the oil price crash in 2014. Despite efforts to reduce borrowings, this remains an issue for the company, with net debt totalling nearly USD3 billion," said AJ Bell's Russ Mould.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Deepmatter, up 78%. The software firm said it will be collaborating with blue chip pharmaceutical firm AstraZeneca in a digital technology venture, designed to speed up the drug delivery process. As part of the collaboration, Astra will assess Deepmatter's DigitalGlassware platform, which enables chemists to share the details of their experiments from anywhere and in real-time. DigitalGlassware works by placing a sensor in a chemical reaction vessel, allowing it to monitor changes in temperature, pressure and UV light levels. The platform also has another probe, which monitors existing environmental conditions. AstraZeneca was down 0.3%.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.